---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/276920278.md"
description: "Geron shares are trading lower after the company reported worse-than-expected Q4 financial results."
datetime: "2026-02-25T17:18:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276920278.md)
  - [en](https://longbridge.com/en/news/276920278.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276920278.md)
---

# 

Geron shares are trading lower after the company reported worse-than-expected Q4 financial results.

### Related Stocks

- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [GERN.US](https://longbridge.com/en/quote/GERN.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)

## Related News & Research

- [Revolution Medicines' experimental cancer pill helps improve survival in late-stage study](https://longbridge.com/en/news/282540793.md)
- [Gossamer Bio Receives Nasdaq Minimum Bid Price Deficiency Notice](https://longbridge.com/en/news/282247265.md)
- [Allogene's blood cancer therapy delays cancer relapse in mid-stage study](https://longbridge.com/en/news/282537381.md)
- [FDA Again Rejects Replimune Skin Cancer Therapy, Says Evidence Falls Short](https://longbridge.com/en/news/282376421.md)
- [iBio Advances to Clinical Stage With IBIO-600 Trial](https://longbridge.com/en/news/282052903.md)